Northern Arc Capital Rallies 9% As Investors Absorb 13% Stake Sale

BANKINGFINANCE
Whalesbook Logo
AuthorKavya Nair|Published at:
Northern Arc Capital Rallies 9% As Investors Absorb 13% Stake Sale

Northern Arc Capital shares climbed over 9% after foreign investors sold a 13% stake at Rs 278 per share on August 31. The stock closed at Rs 311.65 as domestic institutions and funds absorbed the heavy supply. This suggests strong demand, though investors should note that recent financial results showed profit margins tightening due to higher credit costs.

Northern Arc Capital saw a significant change in its shareholding structure on August 31, 2026, when a group of foreign investors sold a 13.12% stake in the company. Despite the heavy supply of shares hitting the market at Rs 278 each, the stock reacted positively, rising 9.06% to close at Rs 311.65 on the National Stock Exchange.

This positive price movement suggests that demand for the company’s stock remains strong, even after a large sell-off by private equity firms. The shares sold by major investors—including Accion International, LeapFrog Investments, and Eight Roads—were quickly bought up by a mix of domestic and international institutions. Notable buyers included Plutus Wealth Management and the Cohesion MK Best Ideas Sub-Trust, which involves market veteran Madhusudan Kela. The entry of these buyers indicates that institutional interest in the company’s business model remains high.

While the market reacted positively to the change in ownership, investors should consider the company's recent financial performance. In the first quarter of the 2027 financial year, Northern Arc Capital reported a 35% year-on-year increase in revenue to Rs 754.08 crore. Net profit also grew by 17.5% to Rs 122 crore. However, profit margins showed signs of pressure, with EBITDA margins dipping to 54.11% from 57.50% in the same period a year earlier.

This compression in margins is a key area for investors to watch. The company faces rising credit costs and higher provisioning requirements, especially within its microfinance and secured business loan portfolios. These costs can impact profitability if they continue to rise. Because the company is still working to diversify its business away from pure non-banking finance company exposures, credit quality remains a critical factor for financial health.

Going forward, the primary monitorable for investors will be whether the company can stabilize its profit margins while maintaining loan growth. The market will also track any future changes in shareholding patterns, as further exits by early institutional investors could influence stock volatility. Investors should observe how the company manages credit risks in its current loan portfolio in the coming quarters.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.